Trends in Medical Devices – Report Bundle (7 Reports)

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Medical Devices Industry Trends Bundle Overview

A rise in disease awareness, improved accessibility to personalized medicine, and technological advancements are transforming the medical device industry. It is helping patients to avoid potential adverse events and reducing unnecessary hospitalizations and outpatient costs. The field has expanded from a handful of drug manufacturers to include many high-end manufacturers.

Accessing the in-depth insight from the Trends in Medical Devices bundle can help you:

  • Make informed decisions about investments, partnerships, and product development
  • Understand your competitors’ strengths and weaknesses, identify areas of opportunity, and develop strategies to stay ahead in the market
  • Anticipate market changes and adjust your strategies accordingly
  • Develop risk management strategies and ensure business continuity

The Trends in Medical Devices bundle is a cost-effective solution as it provides access to multiple reports at a discounted price, compared to buying individual reports:

Click here to download sample pages of every report included in the Trends in Medical Devices bundle

By purchasing the bundle worth $6,665 you can get access to a wealth of information and insights:

  • Market Analysis, Forecasts, and Growth Projections – It presents market data for trending Companion Diagnostics, Point of Care Diagnostics, Remote Patient Monitoring Devices, etc along with an analysis of the opportunities these technologies provide in the medical devices sector.
  • Technology, Macroeconomic and Regulatory Trends –It helps all target audiences to assess the macroeconomic, geopolitical, and regulatory trends that are impacting the market. Moreover, it provides an overview of new technological trends making in-roads to the space and allows businesses to make more informed decisions.
  • Value Chain Analysis –It provides extensive value chain analysis comprising detailed insights across various stages of the value chain, which will help evaluation competitive positioning and identify key growth, M&A and partnership opportunities.

We recommend this valuable source of information to anyone involved in:

  • Strategy & Business Development
  • Market Intelligence
  • M&A
  • Investment Banks
  • Marketing

Currently working in the medical devices industry or those looking to enter this market as manufacturers, consultants, CRO/CMO/CDMO, PE/VC firms, and banks.

Click here to download consolidated sample pages of reports in the Trends in Medical Devices bundle

Report 1: Companion Diagnostics – 2022- Thematic Research

Companion diagnostics (CDx) are a form of personalized, stratified, and precision medicine, and they herald a new era of treatment in which a patient’s treatment will become increasingly individualized. The field has expanded from a handful of oncology drugs with corresponding diagnostics to multiple therapeutic areas, and the number of combinations has grown significantly over the years. However, oncology remains the largest segment for FDA-defined marketed drugs with CDx. The CDx medical devices market continues to increase due to increases in disease, awareness, improved accessibility to personalized medicine, and technological advancements.

Companion Diagnostics

For more insights, Click here to download sample pages for the Trends in Medical Devices Bundle

Report 2: The Aging Population and Medical Devices (2021) – Thematic Research

The increases in life expectancy and fertility declines have substantially shifted population demographics worldwide. Japan has the highest elderly population in the world, followed by Germany and Italy. Innovative medical technologies have tremendous potential to improve elder care. The use of home care devices, wearable devices, and assistive devices support and empower an aging population to lead fulfilling and healthy lives. Also, it has been observed that the aging population is increasingly responding well to using novel devices for remote assistance and medical care.

The Aging Population and Medical Devices

For more insights, Click here to download sample pages for the Trends in Medical Devices Bundle

Report 3: Point of Care Diagnostics (2021) – Thematic Research

Point of care (POC) diagnostics include blood glucose testing, rapid cardiac marker testing, and infectious disease testing. POC testing devices have enhanced the diagnostic capacity for several severe diseases and disorders, with the most significant selling point of the technology being the drastic reduction of turnaround time. The increasing prevalence of infectious diseases, the rising incidences of lifestyle diseases such as cardiac diseases and diabetes, the growing usage of home-based POC devices, and technological advancements in molecular testing are stimulating the demand for POC testing.

Point of Care Diagnostics

For more insights, Click here to download sample pages for the Trends in Medical Devices Bundle

Report 4: Precision and Personalized Medicine – 2022 – Thematic Research

Precision and personalized medicine have the potential to reshape disease treatments and provide patients with better treatment options. Using data and genomics to tailor healthcare plans to each patient significantly contributes to this ability. Furthermore, genetic testing is critical to precision and personalized medicine. It can help predict future diseases in patients and, ultimately, help prevent those diseases. Precision and personalized medicine are currently used most frequently in oncology. However, this medical model would benefit numerous other diseases and treatment areas.

: Precision and Personalized Medicine

For more insights, Click here to download sample pages for the Trends in Medical Devices Bundle

Report 5: Regenerative Medicine in Medical – Thematic Research

Regenerative medicine is relevant to the orthopedic, cardiovascular, neurological, wound care, cancer, and pharmaceutical markets. It has the potential to fully cure patients of diseases, eliminate cancer, and ultimately repair and replace old and damaged tissue. Tissue repair therapies, which use various methods to repair and return damaged and diseased tissues in a patient’s body, are one of the most diverse treatment branches in regenerative medicine. Furthermore, the major players in regenerative medicine are large corporations that can acquire or license intellectual property to develop regenerative medicine programs and smaller developers committed to innovation.

Regenerative Medicine Value Chain Analysis

Regenerative Medicine Value Chain Analysis

For more insights, Click here to download sample pages for the Trends in Medical Devices Bundle

Report 6: Remote Patient Monitoring Devices – 2022 – Thematic Research

Remote patient monitoring (RPM) technology is the use of digital tools and services to track, examine, and collect patient health data and transmit it to medical specialists for additional assessment. RPM tools can significantly better the management of many chronic illnesses. RPM devices’ main objective is to precisely gather a patient’s wide variety of health data, including blood pressure, heart rate, vital signs, weight, and blood sugar levels. The patient stays at home rather than traveling to a healthcare facility, and the patient’s health information is subsequently forwarded to healthcare professionals for monitoring and evaluation.

RPM Value Chain Analysis

RPM Value Chain Analysis

 

For more insights, Click here to download sample pages for the Trends in Medical Devices Bundle

Report 7: Nanotechnology in Medicine – 2022 – Thematic Research

A persistent problem in medicine is the lack of ability to specifically target diseased cells and tissues. Nanomedicine refers to the area of science that combines nanotechnology with drugs or diagnostic molecules to improve the ability to target specific cells or tissues. Players in the nanomedicine market range from private companies that make small annual revenues to large companies that dominate multiple industries, generating large revenues from many patents and FDA-approved drugs. Nanomedicines are a combination of nanotechnology with the drug itself and are required to pass standard regulatory milestones. This includes proven safety and efficacy based on pre-clinical and clinical trials. There are many registered clinical trials in progress that involve nanotechnology for medicine. However, many of these studies as well as clinical trials for new nanomedicines were put on hold during the global COVID-19 pandemic to protect participants and investigators. While North America dominated the market in 2020, accounting for the largest share, GlobalData expects that government funding for new nanomedicines will increase again in 2022, as national budgets and economies recover from the COVID-19 pandemic.

Indications for FDA-Approved Nanomedicines Using Liposomes, 2020

Nanotechnology in Medicine

For more insights, Click here to download sample pages for the Trends in Medical Devices Bundle

Report 1: Companion Diagnostics - Thematic Research

  • Abbott

  • Roche

  • Sysmex

  • bioMérieux

  • Asuragen

  • Thermo Fisher Scientific

  • NimaGen

  • Illumina


Report 2: The Aging Population and Medical Devices (2021) - Thematic Research

  • Abbott Laboratories

  • Apple

  • Becton Dickinson

  • Biotronik

  • Boston Scientific

  • Cochlear

  • DexCom

  • GE Healthcare

  • Google

  • Invacare

  • Medline Industries

  • Medtronic


 Report 3: Point of Care Diagnostics (2021) - Thematic Research

  • Abbot

  • Quidel

  • Danaher

  • Bio-Rad Laboratories

  • Thermo Fisher Scientific

  • Cardinal Health

  • Roche

  • Horiba

  • Werfen

  • Siemens

  • Sinocare


Report 4: Precision and Personalized Medicine – 2022 - Thematic Research

  • Abbott Laboratories

  • Illumina

  • Johnson & Johnson

  • Medtronic

  • Thermo Fisher Scientific

  • Cerner

  • DNAnexus

  • GE Healthcare

  • Roche Sequencing Solutions


Report 5: Regenerative Medicine in Medical - Thematic Research

  • Astellas Pharma

  • Bayer

  • Bristol Myers Squibb

  • Fresenius

  • Gilead

  • Arthrex

  • BioCardia

  • CartiHeal

  • Cook Biotech


Report 6: Remote Patient Monitoring Devices – 2022 - Thematic Research

  • GE Healthcare

  • Medtronic

  • Philips

  • Panasonic

  • Welch Allyn

  • Masimo


Report 7: Nanotechnology in Medicine – 2022 - Thematic Research

  • Janssen

  • Bausch & Lomb

  • Pacira Pharma

  • Ipsen Biopharm

  • Jazz Pharma

  • GE Healthcare

  • Lantheus

  • Hoffman-La Roche

  • Merck

  • Sanofi


Table of Contents

Thematic Research – Companion Diagnostics – 2022

  1. Executive Summary – Brief overview of the Companion Diagnostics theme
  2. Players – List of leaders and business challenges across the Companion Diagnostics value chain
  3. Technology Briefing – Comprehension of the Companion Diagnostics theme
  4. Trends – Major trends influencing the Companion Diagnostics theme

    • Technology trends
    • Macroeconomic trends
    • Regulatory trends

  5. Industry Analysis – Data and insights related to Companion Diagnostics

    • Mergers and acquisitions
    • Timeline

  6. Value Chain – Detailed information on the Companion Diagnostics value chain

    • Immunohistochemistry tests
    • In situ hybridization tests
    • Nucleic acid amplification tests
    • Sanger sequencing tests
    • Next-generation sequencing tests

  7. Companies – List of leading companies and their competitive positions in the Companion Diagnostics theme

    • Public companies
    • Private companies

  8. Further reading
  9. Our thematic research methodology
  10. About GlobalData
  11. Contact Us

Thematic Research: The Aging Population and Medical Devices (2021)

  1. Executive Summary – Brief overview of the aging population and medical devices theme
  2. Players – List of leaders and business challenges across the elderly care value chain
  3. Thematic Briefing – Comprehension of the aging population
  4. Trends – Major trends influencing the aging population

    • Technology trends
    • Macroeconomic trends
    • Regulatory trends

  5. Industry Analysis – Data and insights related to the aging population

    • Healthcare expenditure and the aging population
    • Market size and growth forecasts
    • Case study: intelligent drug dispensing
    • Mergers and acquisitions
    • Timeline

  6. Value Chain – Detailed information on the aging population value chain

    • Patients seeking medical care
    • Elderly care devices
    • Providers

  7. Companies – List of leading companies and their competitive positions in the aging population theme
  8. Glossary
  9. Further Reading
  10. Our Thematic Research Methodology
  11. About GlobalData
  12. Contact Us

Thematic Research: Point of Care Diagnostics (2021)

  1. Executive summary – Brief overview of the Point of Care diagnostics theme
  2. Players – List of leaders and business challenges across the Point of Care diagnostics value chain
  3. Technology briefing – Comprehension of the Point of Care diagnostics theme
  4. Trends – Major trends influencing Point of Care diagnostics

    • Technology trends
    • Macroeconomic trends
    • Regulatory trends

  5. Industry analysis – Data and insights related to Point of Care diagnostics

    • Market segmentation
    • Mergers and acquisitions
    • Timeline

  6. Value chain – Detailed information on Point of Care diagnostics value chain

    • Hematological disorders
    • Metabolic disorders

  7. Companies – List of leading companies and their competitive positions in the Point of Care diagnostics theme

    • Public companies

  8. Glossary
  9. Our thematic research methodology
  10. About GlobalData
  11. Contact Us

Thematic Research – Precision and Personalized Medicine (2022)

  1. Executive Summary – Brief overview of precision and personalized medicine
  2. Players – List of leaders and business challenges across the precision and personalized medicine theme
  3. Technology Briefing – Comprehension of the precision and personalized medicine theme
  4. Trends – Major trends influencing the precision and personalized medicine theme

    • Healthcare trends
    • Macroeconomic trends
    • Regulatory trends

  5. Industry Analysis – Data and insights related to the precision and personalized medicine theme

    • Precision and personalized medicine in oncology
    • Use cases
    • Mergers and acquisitions
    • Timeline

  6. Value Chain – Detailed information on precision and personalized medicine theme

    • Technology
    • Diagnostics and Devices

  7. Companies – List of leading companies and their competitive positions in the precision and personalized medicine theme

    • Public companies
    • Private companies

  8. Further reading
  9. Glossary
  10. Our Thematic Research Methodology
  11. About GlobalData
  12. Contact Us

Thematic Research – Regenerative Medicine in Medical

  1. Executive Summary – Brief overview of the Regenerative Medicine theme
  2. Players – List of leaders and business challenges across the Regenerative Medicine value chain
  3. Technology/Thematic Briefing – Comprehension of the Regenerative Medicine theme

    • Gene therapy
    • Cell therapy
    • Tissue repair

  4. Trends – Major trends influencing the Regenerative Medicine sector

    • Technology trends
    • Macroeconomic trends
    • Regulatory trends

  5. Industry Analysis – Data and insights related to Regenerative Medicine

    • Market size and growth forecasts
    • Mergers and acquisitions
    • Patent trends
    • Social media trends
    • Timeline

  6. Value Chain – Detailed information on Regenerative Medicine value chain

    • Gene therapies
    • Cell therapies
    • Tissue repair

  7. Companies – List of leading companies and their competitive positions in the Regenerative Medicine theme

    • Public companies
    • Private companies

  8. Glossary
  9. Further Reading

    • GlobalData reports

  10. Our Thematic Research Methodology
  11. About GlobalData
  12. Contact Us

Thematic Research – Remote Patient Monitoring Devices – 2022 

  1. Executive Summary – Brief overview of the Remote Patient Monitoring (RPM) theme
  2. Players List of leaders and business challenges across the RPM devices value chain
  3. Technology Briefing – Comprehension of the RPM, its characteristics, and types
  4. Trends – Main trends shaping the RPM theme over the next 12 to 24 months

    • Technology trends
    • Macroeconomic trends
    • Regulatory trends

  5. Industry Analysis – RPM market-related data and insights

    • Market size and growth forecasts
    • RPM devices: COVID-19 use cases
    • Mergers and acquisitions
    • Timeline

  6. Value Chain – Detailed information on GlobalData defined RPM value chain

    • Vital signs monitoring devices
    • Specialized monitoring devices
    • Wearable devices
    • Implantable devices

  7. Companies – List of leading companies and their competitive positions in the RPM devices theme
  8. Sector Scorecards – GlobalData’s scorecards highlighting the impact of the RPM devices theme on various sector  

    • Medical device sector scorecard

  9. Glossary  
  10. Further Reading
  11. Our Thematic Research Methodology
  12. About GlobalData
  13. Contact Us

Thematic Research – Nanotechnology in Medicine – 2022

  1. Executive Summary – Brief overview of the Nanotechnology in medicine theme
  2. Players – List of leaders and business challenges across the nanomedicine value chain
  3. Technology/Thematic Briefing – Comprehension of the nanomedicine theme
  4. Trends – Major trends influencing the nanomedicine sector

    • Technology trends
    • Macroeconomic trends
    • Regulatory trends

  5. Industry Analysis – Data and insights related to the nanomedicine theme

    • Market size and growth forecasts
    • Mergers and acquisitions
    • Timeline

  6. Value Chain – Detailed information on nanomedicine value chain

    • Diagnostics
    • Therapy

  7. Companies – List of leading companies and their competitive positions in the nanomedicine sector

    • Public companies
    • Private companies

  8. Sector Scorecards – GlobalData’s scorecards highlighting the impact of the nanomedicine theme on various sector

    • Medical Devices sector scorecard

  9. Glossary
  10. Further Reading
  11. Our Thematic Research Methodology
  12. About GlobalData
  13. Contact Us

Frequently asked questions

Trends in Medical Devices – Report Bundle (7 Reports) standard reports
Currency USD
$2,950 $6,665 (56% off)

Can be used by individual purchaser only

$5,950 $9,665 (38% off)

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Trends in Medical Devices – Report Bundle (7 Reports) was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Trends in Medical Devices – Report Bundle (7 Reports) in real time.

  • Access a live Trends in Medical Devices – Report Bundle (7 Reports) dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.